Recently, a dysregulation of the CB1R and PPAR-γ protein expression was observed in an animal model of intestinal bowel syndrome (IBS), in which the activation of the CB1R was associated with an improvement of mitochondrial function and gastrointestinal inflammation [40,41]. Here, CNR1 is linked to irritable bowel syndrome.